Cargando…
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study
Tumor mutation burden (TMB) is an independent indicator used to select patients sensitive to immunotherapy. The present study aimed to investigate the clinicopathological and molecular characteristics of patients with hypermutant lung cancer to identify an economical, simple and complementary method...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933761/ https://www.ncbi.nlm.nih.gov/pubmed/33692861 http://dx.doi.org/10.3892/ol.2021.12590 |